Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 2 of 5343 results
Sort by: relevance publication year

Profiling of coexpression of multiple immune checkpoints in the CD4+ and CD8+ T cell components of the clear cell renal cell carcinoma immune infiltrate

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Anne Monette | Nadia Al-Banna | Jean-Pierre Routy | Réjean Lapointe

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer

JOURNAL ARTICLE published March 2014 in Journal for ImmunoTherapy of Cancer

Authors: Z Liu | SB Papa | J Morris | J Maher

Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Kasia Trebska-Mcgowan | Mini Bharathan | Jared J Gartner | Todd D Prickett | Steven A Rosenberg | Paul F Robbins

Professional development session for early career scientists at SITC 2012

JOURNAL ARTICLE published December 2013 in Journal for ImmunoTherapy of Cancer

Authors: Christian M Capitini | William L Redmond | Kimberly A Shafer-Weaver

727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Madeline Dahut | Kristen Fousek | Lucas Horn | Haiyan Qin | Jeffrey Schlom | Claudia Palena

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Roberta Zappasodi | Sadna Budhu | David Schaer | Xia Yang | Hong Zhong | Taha Merghoub | Jedd D Wolchok

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: MacLean Hall | John Mullinax | Erica Royster | Angela Reagan | Ricardo Gonzalez | Jose Pimiento | Shari Pilon-Thomas | Amod Sarnaik

502 Recommended phase 2 dose, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the IL-15 superagonist SO-C101 as monotherapy in patients with advanced/metastatic solid tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Aurelien Marabelle | Stéphane Champiat | Vladimir Galvao | Aung Naing | Filip Janku | Patricia LoRusso | Peter Grell | Richard Sachse | David Bechard | Joachim Kiemle-Kallee | Ellena Garralda

Correspondence on 'Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016' by Sussman et al

JOURNAL ARTICLE published December 2022 in Journal for ImmunoTherapy of Cancer

Authors: Christopher Grant | Garo Hagopian | Thuy B Tran | Gayathri Nagaraj | Justin T Moyers

High expression of a spliced variant of FKBP51 in peripheral blood mononuclear cells of melanoma patients may be related to PDL-1 on tumour and predictive of response to Ipilimumab

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Ester Simeone | Maria fiammetta Romano | Antonio Maria Grimaldi | Assunta Esposito | Marcello Curvietto | Miriam Paone | Giovanni Rinaldi | Gianluca Di monta | Massimiliano Di marzo | Federica Hauber | Lucia Festino | Anna D'Angelillo | Simona Romano | Stefania Staibano | Gennaro Ilardi | Rita Bisogni | Nicola Mozzillo | Paolo Antonio Ascierto

Mitochondrial activity regulates T cell memory, self renewal and anti tumor function in CD8+ T cells

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Madhusudhanan Sukumar | Jie Liu | Joseph Crompton | Mahadev Rao | Yun Ji | Toren Finkel | Luca Gattinoni | Nicholas Restifo

712 Preclinical characterization of GT-00A x IL15: A novel IL-15-based immunocytokine with unique tumor targeting properties

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Anika Jaekel | Patrik Kehler | Timo Lischke | Christoph Goletz | Anke Flechner | Antje Danielczyk | Johanna Gellert

Correction: Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study

JOURNAL ARTICLE published October 2022 in Journal for ImmunoTherapy of Cancer

62 Applying machine vision to empower preclinical development of cell engager and adoptive cell therapeutics in patient-derived organoid models of solid tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Sonal Khare | Chi-Sing Ho | Madhavi Kannan | Brian Larsen | Brandon Mapes | Jenna Shaxted | Jagadish Venkataraman | Ameen Salahudeen

249 Characterization of unresectable and/or metastatic solid tumors patients treated with systemic anticancer therapy in first-line settings: a pan-tumor community-oncology based study

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Elise Wu | Sneha Sura | Alexander Spira

564 Single-cell transcriptomic analysis of immune compartments following combination immunotherapy treatment in poorly immunogenic tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Ang Cui | Kelly Moynihan | Shuqiang Li | Chensu Wang | Jackson Southard | Nir Hacohen | Darrell Irvine

Cyclophosphamide mechanism of action in preclinical tecemotide studies

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Ken Hance | Robert Tighe | Jin Qi | William Hastings | Guozhong Qin | Bo Marelli | Hong Wang | Huakui Yu | Yanping Zhang | Xiaomei Xu | Wilson Guzman | Masie Wong | Giorgio Kradjian | Beatrice Brunkhorst | Helen Sabzevari | Yan Lan | Robert Hofmeister | Michael Wolf

Modulation of chemically induced renal carcinogenesis by Chrysin via inhibition of oxidative stress, hyper-proliferation and inflammation at preclinical stage

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Summya Rashid | Sarwat Sultana

Immunosuppression through HNF-1β signaling in human ovarian clear cell cancer

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Hiroshi Nishio | Juri Sugiyama | Tomonori Yaguchi | Daisuke Aoki | Yutaka Kawakami

Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization

JOURNAL ARTICLE published 2013 in Journal for ImmunoTherapy of Cancer

Authors: Alisha Holtzhausen | Kathy Evans | Brent A Hanks